首页> 美国卫生研究院文献>Cell Communication and Signaling : CCS >Diverse regulatory manners of human telomerase reverse transcriptase
【2h】

Diverse regulatory manners of human telomerase reverse transcriptase

机译:人端粒酶逆转录酶的多种调控方式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human telomerase reverse transcriptase (hTERT) is the core subunit of human telomerase and plays important roles in human cancers. Aberrant expression of hTERT is closely associated with tumorigenesis, cancer cell stemness maintaining, cell proliferation, apoptosis inhibition, senescence evasion and metastasis. The molecular basis of hTERT regulation is highly complicated and consists of various layers. A deep and full-scale comprehension of the regulatory mechanisms of hTERT is pivotal in understanding the pathogenesis and searching for therapeutic approaches. In this review, we summarize the recent advances regarding the diverse regulatory mechanisms of hTERT, including the transcriptional (promoter mutation, promoter region methylation and histone acetylation), post-transcriptional (mRNA alternative splicing and non-coding RNAs) and post-translational levels (phosphorylation and ubiquitination), which may provide novel perspectives for further translational diagnosis or therapeutic strategies targeting hTERT.
机译:人类端粒酶逆转录酶(hTERT)是人类端粒酶的核心亚基,在人类癌症中发挥重要作用。 hTERT的异常表达与肿瘤发生,维持癌细胞干性,细胞增殖,凋亡抑制,衰老逃避和转移密切相关。 hTERT调节的分子基础非常复杂,由不同的层组成。对hTERT调控机制的深入和全面理解对于理解发病机理和寻找治疗方法至关重要。在这篇综述中,我们总结了有关hTERT多种调控机制的最新进展,包括转录(启动子突变,启动子区域甲基化和组蛋白乙酰化),转录后(mRNA选择性剪接和非编码RNA)和翻译后水平。 (磷酸化和泛素化),这可能为进一步针对hTERT的翻译诊断或治疗策略提供新颖的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号